Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids

Bingbing Song1, Juan Carlos G Marvizón

  • 1Center for Neurovisceral Sciences and Women's Health, Division of Digestive Diseases, Department of Medicine, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095, USA.

Insights

Peptidases degrade endogenous opioids, reducing mu-opioid receptor (MOR) activation. Inhibiting these peptidases enhances opioid potency and MOR-1 internalization in the spinal cord.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Endogenous opioids modulate pain and other physiological processes.
  • Mu-opioid receptors (MOR) are key targets for opioid analgesics.
  • The role of peptidases in modulating endogenous opioid signaling at MOR is not fully understood.

Purpose of the Study:

  • To investigate the impact of peptidases on the activation of mu-opioid receptor 1 (MOR-1) by endogenous opioids.
  • To determine which specific peptidases degrade enkephalins and dynorphin A.
  • To elucidate the role of peptidases in the regulation of endogenous opioid signaling in the rat spinal cord.

Main Methods:

  • Measurement of MOR-1 internalization in rat spinal cord slices.
  • Utilized a mixture of peptidase inhibitors: amastatin (aminopeptidases), captopril (dipeptidyl carboxypeptidase), and phosphoramidon (neutral endopeptidase).
  • Employing veratridine or KCl to stimulate endogenous opioid release and confocal microscopy to visualize MOR-1 expressing neurons.

Main Results:

  • Peptidase inhibitors significantly increased the potency of Leu-enkephalin and dynorphin A for MOR-1 internalization.
  • Specific inhibitors revealed that aminopeptidases and neutral endopeptidase degrade dynorphin A, while all three peptidases degrade enkephalins.
  • Veratridine-induced MOR-1 internalization, attributed to released opioids, was dependent on Ca(2+) and blocked by CTAP, with neutral endopeptidase being the primary enzyme involved.

Conclusions:

  • Peptidases play a crucial role in limiting the activation of extrasynaptic MOR-1 in dorsal horn neurons.
  • The degradation of endogenous opioids by peptidases fine-tunes MOR signaling.
  • Understanding peptidase activity is vital for developing effective pain management strategies targeting the opioid system.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...